DNA X, Inc.
Income Statement
| Line Item | FY2018 |
|---|---|
| Revenue | $135.7M |
| Cost of Revenue | $87.6M |
| Gross Profit | $48.1M |
| Gross Margin | 35.4% |
| Operating Expenses | |
| Research & Development | $23.2M |
| SG&A Expense | $7.2M |
| Operating Income | $5.4M |
| Operating Margin | 4.0% |
| Interest Expense | — |
| Pretax Income | $2.0M |
| Income Tax Expense | $754.0K |
| Net Income | $1.3M |
| Net Margin | 0.9% |
| EPS (Basic) | $-0.29 |
| EPS (Diluted) | $-0.29 |
| Shares Outstanding (Basic) | 140.3M |
| Shares Outstanding (Diluted) | 140.3M |
| Dividends Per Share | — |